All Blogs / Industries / Medical / Pharmaceutical / New


Cardinal Health CEO George Barrett is a Rock God

Jimmy Page, Eric Clapton, and…George Barrett? Not convinced? Check out the video below, which shows Cardinal Health Chairman and CEO George Barrett onstage at The Rock and Roll Hall of Fame Roadshow concert. Highlights include: Barrett's...Show More Summary

The Last Post

Well, the last post here at Corante. I'm going to shut off commenting to all the recent posts, and send the export file over to the people at Science Translational Medicine, and Monday morning we'll start anew at: http://blogs.sciencemag.org/pipeline I hope to see everyone over there. Show More Summary

The GSK Layoffs Continue, By Proxy

You may recall that when GlaxoSmithKline cut down the Research Triangle site, that "up to 450" employees were said to be transferred to a contract organization, Parexel. In many cases, these people were doing the same jobs, in the same buildings, but were now doing it for less money. Show More Summary

Weekly Roundup 7.31.15

It is the end of July! Even though childhood is far away in my rear view mirror, my year is still defined by the school calendar and I find myself lamenting a bit that the summer is already two-thirds over. … Continue reading ?

Pharmalot… PharmaWhat?… Until We Meet Again…

After a brief, but rewarding stay here at The Wall Street Journal, we are taking our Pharmalot act to a different theater.

News Roundup, July 2015: CVS Health, Allergan, Specialty Pharmacies, and Amy Schumer

The hot and hazy days of summer are here. Cool off with my refreshing selection of articles that cut through the steamy haze. In this issue: A handy primer on CVS Health’s history and strategy Allergan’s CEO explains how channel consolidation...Show More Summary

The Move is Nigh

The day for the big Pipeline move is almost at hand! Friday's posts here will be the last on the Corante site, and the new one at Science Translational Medicine will go live on Monday morning. I'll post the new URL shortly. I wantedShow More Summary

Another Alzheimer's IPO

I've been saying a lot of unkind things about Axovant, the insta-company that's taking a discarded GSK Alzheimer's candidate and running with it. But thanks to Adam Feuerstein, I have another company to roll my eyes about. They have a completely different Alzheimer's plan - they've taken a discarded Pfizer candidate and are running with it. Show More Summary

Former Teva Employee Blames Firing on Helping Feds With Bribery Probe

A former Teva employee claims she was fired for helping U.S. officials with their investigation into FCPA violations.

Pharmalot.. Pharmalittle.. Good Morning: We’re Catching up on Glaxo, MannKind and Lots More!!

Good morning, everyone, and how are you today? The heat continues to rise higher here on the Pharmalot campus, where we are hoping for storm clouds to wash away the humidity that has so far characterized the past few days. One can dream,...Show More Summary

Another California County Wants Pharma to Pay for Drug Take-Backs

Yet another California county plans to ask the pharmaceutical industry to fund a drug take-back program.

Cutbacks at C&E News

Word is this morning that Chemical and Engineering News has let at least 8 staff members go in a reorganization, including former editor-in-chief Maureen Rouhi. The magazine outsourced its advertising sales some months ago, rather than...Show More Summary

Sanofi Pays to Get Back Into Oncology

You may recall that Sanofi basically threw its hands up in the air some time back about its entire oncology R&D efforts. Or, since they're so relentlessly French over there, perhaps it was the Gallic Shrug instead. Either one would fit - the company just wasn't seeming to get anywhere. Show More Summary

AllTrials in the USA

We’re excited to announce that 50 patient groups, consumer organisations and medical societies have come together to launch AllTrials USA today! These groups have said: "We are calling on everyone in our sector to join us in supporting the AllTrials campaign. Show More Summary

Serious Risks About Existing Drugs Aren’t Given to Trial Participants

New research finds some serious risks are not disclosed on consent forms given to trial participants for studies involving approved drugs.

Pharmalot.. Pharmalittle.. Good Morning: We’re Catching up on NantKwest, Biogen and Lots More!!

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Show More Summary

Copyright © 2015 Regator, LLC